HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F15%3A00059248" target="_blank" >RIV/00023001:_____/15:00059248 - isvavai.cz</a>
Alternative codes found
RIV/75010330:_____/15:00010782
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0140673614611831" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0140673614611831</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S0140-6736(14)61183-1" target="_blank" >10.1016/S0140-6736(14)61183-1</a>
Alternative languages
Result language
angličtina
Original language name
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Original language description
Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the intended drug target.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet
ISSN
0140-6736
e-ISSN
—
Volume of the periodical
385
Issue of the periodical within the volume
9965
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
351-361
UT code for WoS article
000348509000028
EID of the result in the Scopus database
—